Finally, I offer novel insights into the diagnosis and treatment of monoaminergic axon disorders, with particular emphasis on the contribution of the PLA2 pathway—especially calcium-independent PLA2 (iPLA2)—to the pathophysiology of schizophrenia. Here, PLA2G6 is linked to schizophrenia.